ProMIS Neurosciences (PMN) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 12, 2026.
Summary
ProMIS Neurosciences (PMN) has outperformed Quantum Cyber N.V. (QUCY) over the past year, losing 21.3% versus a loss of 34.4%. Quantum Cyber N.V. is the larger company by market cap ($86.6 million vs $84.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PMN | QUCY |
|---|---|---|
| Share price | $9.45 | $1.03 |
| Market cap | $84.74M | $86.59M |
| 1-day change | -1.66% | -23.70% |
| YTD return | +38.36% | -8.04% |
| 1-year return | -21.25% | -34.39% |
| 5-year return | -95.80% | — |
| EPS (TTM) | $-11.65 | $-2.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $27.40 | $4.93 |
| 52-week low | $6.27 | $0.30 |
| Distance from 52-week high | -65.51% | -79.11% |
| Analyst consensus | none | none |
| Avg. price target upside | +350.90% | +773.79% |
| Average volume | 82.46K | 689.09K |
| Shares outstanding | 8.97M | 84.07M |
| Employees | 10 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PMN has outperformed QUCY by 13.1 percentage points over the past year.
About ProMIS Neurosciences
PMN stock →ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
PMN vs QUCY FAQ
Which is bigger, ProMIS Neurosciences or Quantum Cyber N.V.?
Quantum Cyber N.V. (QUCY) is larger, with a market capitalization of $86.59M compared with $84.74M for ProMIS Neurosciences (PMN).
Which stock has performed better over the past year, PMN or QUCY?
PMN returned -21.25% over the past 12 months, compared with -34.39% for QUCY (price return, excluding dividends). Past performance does not predict future results.
Are ProMIS Neurosciences and Quantum Cyber N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.